INFI - Infinity Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts3333
Avg. Estimate-0.17-0.17-0.23-0.74
Low Estimate-0.18-0.2-0.25-0.79
High Estimate-0.16-0.14-0.22-0.7
Year Ago EPS-0.14-0.18-0.83-0.23
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts3233
Avg. EstimateN/A1M22M670k
Low EstimateN/AN/A22MN/A
High EstimateN/A2M22M2M
Year Ago SalesN/AN/A6M22M
Sales Growth (year/est)N/AN/A266.70%-97.00%
Earnings History12/30/20173/30/20186/29/20189/29/2018
EPS Est.-0.25-0.18-0.2-0.15
EPS Actual-0.14-0.18-0.120.23
Difference0.1100.080.38
Surprise %44.00%0.00%40.00%253.30%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate-0.17-0.17-0.23-0.74
7 Days Ago-0.17-0.17-0.23-0.74
30 Days Ago-0.13-0.04-0.57-0.5
60 Days Ago-0.13-0.04-0.57-0.5
90 Days Ago-0.16-0.04-0.62-0.57
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 Days1122
Up Last 30 Days1122
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days2111
Growth EstimatesINFIIndustrySectorS&P 500
Current Qtr.-21.40%N/AN/A0.48
Next Qtr.5.60%N/AN/A0.40
Current Year72.30%N/AN/A0.21
Next Year-221.70%N/AN/A0.10
Next 5 Years (per annum)89.63%N/AN/A0.11
Past 5 Years (per annum)19.94%N/AN/AN/A